Author's Profile

Marina Temkin

Financial Writer

Marina Temkin covered the venture capital ecosystem from 2021 to 2024, based in San Francisco. Previously with Venture Capital Journal, Marina wrote about the VC industry, and she was a reporter with Mergermarket in New York and San Francisco. She also has been a financial analyst and is a CFA charterholder. Marina received an economics degree from the University of California, Davis, and she attended the CUNY Graduate School of Journalism.

m-temkin-low-res-round.png

Articles by Marina Temkin

Investors bet on the technologically unproven field of quantum computing

Scientists are still working to develop the next level of quantum computing. But venture capitalists have already invested $1.02 billion into quantum computing companies so far this year.
September 12, 2021

‘Earned wage’ startups winning over VCs with an ESG agenda

Venture capitalists are on the hunt for ESG-focused companies, prompting a surge of investment into startups offering earned wage access products, an alternative to traditional payday lending.
September 5, 2021

Startups in Latin America grab record sums of venture capital

VCs have invested $8.8 billion in Latin American startups this year, as investors chase the digital transformation of sectors including fintech, real estate and ecommerce in one of the world’s busiest markets.
August 16, 2021

How ‘solo VCs’ are changing the venture game

The massive capital influx into venture investing is giving rise to new types of investors, including so-called “solo capitalists,” who are stepping up to lead a growing number of deals.
July 29, 2021

Robinhood’s rescue: The VC deal that turned a crisis into one of 2021’s biggest IPOs

Earlier this year, Robinhood’s VC backers scrambled to arrange $3.5 billion in immediate debt funding for the platform amid the GameStop craze. A few months later, that emergency financing has fueled one of the year’s most high-profile public debuts.
July 27, 2021

Real estate tech is bouncing back from its pandemic slump

As pandemic-related shutdowns are phasing out, the commercial and residential real estate tech segments are seeing renewed interest from venture capitalists.
June 27, 2021

Psychedelic IPOs build momentum as Atai Life Sciences goes public

In its IPO this week, Atai Life Sciences became the third biotech company focused on psychedelic treatment for mental health disorders to list on a major US stock exchange.
June 17, 2021

Wall Street wins signal the start of a synthetic biology revolution

One investor is calling it “the most important technological revolution of our time.”
June 6, 2021

Fintech takes aim at a $400B healthcare puzzle

As healthcare costs in the US continue to rise, fintech startups like PayZen are seeking solutions to help patients pay their bills and hospitals stay afloat.
May 23, 2021

VC is performing better than ever. Then why are so few first-time funds being raised?

VC fundraising set a record in 2020, bringing in nearly $80 billion. But that excitement isn’t extending to first-time fund managers.
May 3, 2021